Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions

References

• Loh Y-H, Agarwal S, Park I-H, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113:5476-9; PMID:19299331; http://dx.doi.org/10.1182/blood-2009-02-204800
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25:100-6; PMID:17206138; http://dx.doi.org/10.1038/nbt1274
   PubMed Web of Science ®Google Scholar
• Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, Zund G, Hoerstrup SP. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007; 116:I64-70; PMID:17846327; http://dx.doi.org/10.1161/CIRCULATIONAHA.107.184051
   PubMed Web of Science ®Google Scholar
• Schmidt D, Achermann J, Odermatt B, Genoni M, Zund G, Hoerstrup SP. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis 2008; 17:446-55; PMID:18751475
   PubMed Web of Science ®Google Scholar
• Weber B, Emmert MY, Behr L, Schoenauer R, Brokopp C, Drögemüller C, Modregger P, Stampanoni M, Vats D, Rudin M, et al. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials 2012; 33:4031-43; PMID:22421386; http://dx.doi.org/10.1016/j.biomaterials.2011.11.087
   PubMed Web of Science ®Google Scholar
• Zaim M, Karaman S, Cetin G, Isik S. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells. Ann Hematol 2012; 91:1175-86; PMID:22395436; http://dx.doi.org/10.1007/s00277-012-1438-x
   PubMed Web of Science ®Google Scholar
• Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, Wagner W. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 2010; 9:54-63; PMID:19895632; http://dx.doi.org/10.1111/j.1474-9726.2009.00535.x
   PubMed Web of Science ®Google Scholar
• Phermthai T, Suksompong S, Tirawanchai N, Issaragrisil S, Julavijitphong S, Wichitwiengrat S, Silpsorn D, Pokathikorn P. Epigenetic Analysis and Suitability of Amniotic Fluid Stem Cells for Research and Therapeutic Purposes. Stem Cells Dev 2013; 22:1319-28; PMID:23249260; http://dx.doi.org/10.1089/scd.2012.0371
   PubMed Web of Science ®Google Scholar
• Jelinic P, Shaw P. Loss of imprinting and cancer. J Pathol 2007; 211:261-68; PMID:17177177; http://dx.doi.org/10.1002/path.2116
   PubMed Web of Science ®Google Scholar
• Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467:285-90; PMID:20644535; http://dx.doi.org/10.1038/nature09342
   PubMed Web of Science ®Google Scholar
• Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, et. al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther 2012; 20:1953-67; PMID:22760542; http://dx.doi.org/10.1038/mt.2012.117
   PubMed Web of Science ®Google Scholar
• Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, Hock H, Hochedlinger K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009 ; 41:968-76; PMID:19668214; http://dx.doi.org/10.1038/ng.428
   PubMed Web of Science ®Google Scholar
• Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Prot 2011; 6:689-700; http://dx.doi.org/10.1038/nprot.2011.318
   PubMed Web of Science ®Google Scholar
• Chen G, Gulbrason DR, Hou Z, Bolin J, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011; 8:424-29; PMID:21478862; http://dx.doi.org/10.1038/nmeth.1593
   PubMed Web of Science ®Google Scholar
• Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, Yu H, Jin S, Wei Z, Chen F, Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 2009; 18:4340-49; PMID:19679563; http://dx.doi.org/10.1093/hmg/ddp386
   PubMed Web of Science ®Google Scholar
• Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, Khoueiry G, Lafferty J, McGinn JT, Brodman M, Fuster V, et al. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogramm 2010; 12:117-25; http://dx.doi.org/10.1089/cell.2009.0077
   PubMed Web of Science ®Google Scholar
• Wolfrum K, Wang Y, Prigione A, Sperling K, Lehrach H, Adjaye J. The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One 2010; 5:e13703; PMID:21060825; http://dx.doi.org/10.1371/journal.pone.0013703
   PubMed Web of Science ®Google Scholar
• Lu HE, Yang YC, Chen SM, Su HL, Huang PC, Tsai MS, Wang TH, Tseng CP, Hwang SW. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells. Exp Cell Res 2013; 319:498-505; PMID:23041301; http://dx.doi.org/10.1016/j.yexcr.2012.09.017
   PubMed Web of Science ®Google Scholar
• Fan Y, Luo Y, Chen X, Li Q, Sun X. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette. J Reprod Dev 2012; 58:404-9; PMID:22498813; http://dx.doi.org/10.1262/jrd.2011-046
   PubMed Web of Science ®Google Scholar
• Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324:797-801; PMID:19325077; http://dx.doi.org/10.1126/science.1172482
   PubMed Web of Science ®Google Scholar
• Cheng L, Hansen NF, Zhao L, Du Y, Zou C, Donovan FX, Chou BK, Zhou G, Li S, Dowey SN, et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 2012; 10:337-44; PMID:22385660; http://dx.doi.org/10.1016/j.stem.2012.01.005
   PubMed Web of Science ®Google Scholar
• Beers J, Gulbranson DR, George N, Siniscalchi LI, Jones J, Thomson JA, Chen G. Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc 2012; 7:2029-40; PMID:23099485; http://dx.doi.org/10.1038/nprot.2012.130
   PubMed Web of Science ®Google Scholar
• Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 2011; 117:e109-19; PMID:21296996; http://dx.doi.org/10.1182/blood-2010-07-298331
   PubMed Web of Science ®Google Scholar
• Chan EM, Chan EM, Ratanasirintrawoot S, Park I-H, Manos PD, Loh Y-H, Huo H, Miller JD, Hartung O, Rho J, et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 2009; 27:1033-37; PMID:19826408; http://dx.doi.org/10.1038/nbt.1580
   PubMed Web of Science ®Google Scholar
• Nanbo A, Sugden A, Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 2007; 26:4252-62; PMID:17853891; http://dx.doi.org/10.1038/sj.emboj.7601853
   PubMed Web of Science ®Google Scholar
• Liang G, Zhang Y. Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res 2013; 23:49-69; PMID:23247625; http://dx.doi.org/10.1038/cr.2012.175
   PubMed Web of Science ®Google Scholar
• Liang G, He J, Zhang Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat Cell Biol 2012; 14:457-66; PMID:22522173; http://dx.doi.org/10.1038/ncb2483
   PubMed Web of Science ®Google Scholar
• Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012; 483:598-602; PMID:22388813; http://dx.doi.org/10.1038/nature10953
   PubMed Web of Science ®Google Scholar
• Li R, Liang J, Ni S, Zhou T, Qing X, Li H, He W, Chen J, Li F, Zhuang Q, et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010; 7:51-63; PMID:20621050; http://dx.doi.org/10.1016/j.stem.2010.04.014
   PubMed Web of Science ®Google Scholar
• Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010; 7:64-77; PMID:20621051; http://dx.doi.org/10.1016/j.stem.2010.04.015
   PubMed Web of Science ®Google Scholar
• Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008; 454:49-55; PMID:18509334; http://dx.doi.org/10.1038/nature07056
   PubMed Web of Science ®Google Scholar
• Liang G, Taranova O, Xia K, Zhang Y. Butyrate promotes induced pluripotent stem cell generation. J Biol Chem 2010; 285:25516-21; PMID:20554530; http://dx.doi.org/10.1074/jbc.M110.142059
   PubMed Web of Science ®Google Scholar
• Buganim Y, Faddah DA, Cheng AW, Itskovich E, Markoulaki S, Ganz K, Klemm SL, van Oudenaarden A, Jaenisch R. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 2012; 150:1209-22; PMID:22980981; http://dx.doi.org/10.1016/j.cell.2012.08.023
   PubMed Web of Science ®Google Scholar
• Theunissen TW, Jaenisch R. Molecular control of induced pluripotency. Cell Stem Cell 2014; 14:720-34; PMID:24905163; http://dx.doi.org/10.1016/j.stem.2014.05.002
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 2014; 156:663-77; PMID:24529372; http://dx.doi.org/10.1016/j.cell.2014.01.005
   PubMed Web of Science ®Google Scholar
• Goding CR, Pei D, Lu X. Cancer: pathological nuclear reprogramming. Nature Reviews Cancer 2014; 14:568-73; PMID:25030952; http://dx.doi.org/10.1038/nrc3781
   PubMed Web of Science ®Google Scholar
• Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD, Buetow KH, et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008; 2:437-47; PMID:18462694; http://dx.doi.org/10.1016/j.stem.2008.03.021
   PubMed Web of Science ®Google Scholar
• Krejci J, Uhlirova R, Galiova G, Kozubek S, Smigova J, Bartova E. Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation. J Cell Physiol 2009; 219:677-87; PMID:19202556; http://dx.doi.org/10.1002/jcp.21714
   PubMed Web of Science ®Google Scholar
• Li X, Li L, Pandey R, Byun JS, Gardner K, Qin Z, Dou Y. The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network. Cell Stem Cell 2012; 11:163-78; PMID:22862943; http://dx.doi.org/10.1016/j.stem.2012.04.023
   PubMed Web of Science ®Google Scholar
• Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, Brodsky RA, Ohm JE, Yu W, Baylin SB, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010; 28:713-20; PMID:20201064; http://dx.doi.org/10.1002/stem.402
   PubMed Web of Science ®Google Scholar
• Huangfu D,R Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA. Induction of pluripotent stem cells by defined factors is greatly improved by small molecule compounds. Nat Biotechnol 2008; 26:795-97; PMID:18568017; http://dx.doi.org/10.1038/nbt1418
   PubMed Web of Science ®Google Scholar
• Martí M, Mulero L, Pardo C, Morera C, Carrió M, Laricchia-Robbio L, Esteban CR, Belmonte JCI. Characterization of pluripotent stem cells. Nat Prot 2013; 8:223-53; PMID:Can't; http://dx.doi.org/10.1038/nprot.2012.154
   PubMed Web of Science ®Google Scholar
• Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 2014; 158:1254-69; PMID:25215486; http://dx.doi.org/10.1016/j.cell.2014.08.029
   PubMed Web of Science ®Google Scholar
• Müller FJ, Goldmann J, Löser P, Loring JF. A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell 2010; 6:412-14; PMID:20452314; http://dx.doi.org/10.1016/j.stem.2010.04.009
   PubMed Web of Science ®Google Scholar
• Müller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2013; 8:315-17; http://dx.doi.org/10.1038/nmeth.1580
   Web of Science ®Google Scholar
• Lee KI, Kim HT, Hwang DY. Footprint- and xeno-free human iPSCs derived from urine cells using extracellular matrix-based culture conditions. Biomaterials 2014; 35:8330-38; PMID:24994040; http://dx.doi.org/10.1016/j.biomaterials.2014.05.059
   PubMed Web of Science ®Google Scholar
• Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 2009; 4:275-91; PMID:19317646; http://dx.doi.org/10.2217/17460751.4.2.275
   PubMed Web of Science ®Google Scholar
• Jiang G, Di Bernardo J, Maiden MM, Villa-Diaz LG, Mabrouk OS, Krebsbach PH, O'Shea KS, Kunisaki SM. Human transgene-free amniotic fluid-derived induced pluripotent stem cells for autologous cell therapy. Stem Cells Dev 2014; 23:2613-25; PMID:25014361; http://dx.doi.org/10.1089/scd.2014.0110
   PubMed Web of Science ®Google Scholar
• Drozd AM, Walczak MP, Piaskowski S, Stoczynska-Fidelus E, Rieske P, Grzela DP. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system. Stem Cell Res Ther 2015; 6:122; PMID:26088261; http://dx.doi.org/10.1186/s13287-015-0112-3
   PubMed Web of Science ®Google Scholar